The situation of corona virus outbreak is getting worse. Raging in China for 2 months from the end of 2019, and starting in late February 2020, the epidemic is moving to Europe and the United States is now leading the number of people identified with Covid-19. Not only relying on federal government measures, every state in the United States has started taking measures to reduce the spread of this deadly virus on its own.
A hospital in New Jersey is testing a new way to protect health workers and patients. It is disinfecting hospital surfaces and items with a slightly nano-biotechnology microbiological removal system, called MSS for short.
This is a large-scale application system by using a special nebulizer to spray micro-microbial nanoparticles onto surfaces and objects. The nano vapor solution not only disinfects but also creates a special layer of biodegradable coatings, so that it continues to protect surfaces for long periods. Bacteria, molds and even viruses such as the new corona virus do not survive for weeks, even months after spraying.
In this experiment, the amount of microorganisms was reduced by 99.8% after 70 days of nano-spraying and the effect continued until the 90th day.
Dr. Maurizio Miglietta, Head of Surgery Department of Hudson Regional Hospital, USA, commented that the MSS system can spray microorganic pesticides very quickly on a large scale in places such as hospitals, shopping centers, buildings. office buildings, schools, religious ceremonies, airports and public transit stations. Dr. Miglietta is also the Clinical Medical Director of Nano Steam Biotechnology, so the Hudson Regional Hospital was the first to use this solution.
Hudson Regional Hospital CEO Dr. Nizar Kifaieh also said that in the absence of a cure for Covid-19, the best strategy to reduce the curve of the disease situation is to implement the Precautions to keep patients and medical personnel safe. The nano vapor biotechnology system is the "game changer" in preventing spread of disease.
The nano vapor solution was approved by the US Food and Drug Administration (FDA). Only the previous solution has not been tested on a large scale in a high-risk environment today, so many people are eager to see the infection rates of health workers in regional hospitals. What is Hudson compared to other hospitals next month.
